Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-02-23 7:57 pm Sale | 2021-02-19 | 13D | CELLULAR BIOMEDICINE GROUP, IN CBMG | Novartis Pharma AG | 0 0.000% | -1,458,257 (Position Closed) | Filing History |
| 2021-02-19 7:50 pm Sale | 2021-02-19 | 13D | CELLULAR BIOMEDICINE GROUP, IN CBMG | Dangdai International Group Co. Ltd | 0 0.000% | -2,270,000 (Position Closed) | Filing History |
| 2021-02-19 3:44 pm Sale | 2021-02-19 | 13D | CELLULAR BIOMEDICINE GROUP, IN CBMG | Liu Tony | 0 0.000% | -1,712,920 (Position Closed) | Filing History |
| 2020-08-14 4:32 pm Unchanged | 2020-08-11 | 13D | CELLULAR BIOMEDICINE GROUP, IN CBMG | Novartis Pharma AG | 1,458,257 7.500% | 0 (Unchanged) | Filing History |
| 2020-08-12 11:16 am Unchanged | 2020-08-11 | 13D | CELLULAR BIOMEDICINE GROUP, IN CBMG | Dangdai International Group Co. Ltd | 2,270,000 11.700% | 0 (Unchanged) | Filing History |
| 2020-08-12 08:51 am Unchanged | 2020-08-11 | 13D | CELLULAR BIOMEDICINE GROUP, IN CBMG | Liu Tony | 1,712,920 8.800% | 0 (Unchanged) | Filing History |
| 2020-06-24 7:31 pm Unchanged | 2020-06-24 | 13D | CELLULAR BIOMEDICINE GROUP, IN CBMG | Dangdai International Group Co. Ltd | 2,270,000 11.800% | 0 (Unchanged) | Filing History |
| 2020-06-24 4:38 pm Unchanged | 2020-06-24 | 13D | CELLULAR BIOMEDICINE GROUP, IN CBMG | HHLR ADVISORS LTD. | 235,214 1.200% | 0 (Unchanged) | Filing History |
| 2020-06-24 4:35 pm Purchase | 2020-06-24 | 13D | CELLULAR BIOMEDICINE GROUP, IN CBMG | Liu Tony | 1,712,920 8.800% | 676,880 (+65.33%) | Filing History |
| 2020-04-01 09:39 am Unchanged | 2020-03-30 | 13D | CELLULAR BIOMEDICINE GROUP, IN CBMG | Sailing Capital Overseas Investments Fund LP | 1,712,920 8.900% | 0 (Unchanged) | Filing History |
| 2020-04-01 09:37 am Unchanged | 2020-03-30 | 13D | CELLULAR BIOMEDICINE GROUP, IN CBMG | TF Venture Capital Management Co. Ltd. | 358,974 1.800% | 0 (Unchanged) | Filing History |
| 2020-04-01 09:33 am Sale | 2020-03-30 | 13D | CELLULAR BIOMEDICINE GROUP, IN CBMG | Liu Tony | 1,036,040 5.400% | -68,893 (-6.24%) | Filing History |
| 2020-03-31 10:16 am Unchanged | 2020-03-30 | 13D | CELLULAR BIOMEDICINE GROUP, IN CBMG | Dangdai International Group Co. Ltd | 2,270,000 11.800% | 0 (Unchanged) | Filing History |
| 2020-03-30 4:15 pm Unchanged | 2020-03-30 | 13D | CELLULAR BIOMEDICINE GROUP, IN CBMG | HHLR ADVISORS LTD. | 235,214 1.200% | 0 (Unchanged) | Filing History |
| 2020-02-24 1:50 pm Unchanged | 2020-02-21 | 13D | CELLULAR BIOMEDICINE GROUP, IN CBMG | Dangdai International Group Co. Ltd | 2,270,000 11.800% | 0 (Unchanged) | Filing History |
| 2020-02-21 4:12 pm Unchanged | 2020-02-21 | 13D | CELLULAR BIOMEDICINE GROUP, IN CBMG | TF Venture Capital Management Co. Ltd. | 358,974 1.800% | 0 (Unchanged) | Filing History |
| 2020-02-21 4:10 pm Unchanged | 2020-02-21 | 13D | CELLULAR BIOMEDICINE GROUP, IN CBMG | HHLR ADVISORS LTD. | 235,214 1.200% | 0 (Unchanged) | Filing History |
| 2020-02-21 4:08 pm Unchanged | 2020-02-21 | 13D | CELLULAR BIOMEDICINE GROUP, IN CBMG | Sailing Capital Overseas Investments Fund LP | 1,712,920 8.900% | 0 (Unchanged) | Filing History |
| 2020-02-21 4:05 pm Purchase | 2020-02-21 | 13D | CELLULAR BIOMEDICINE GROUP, IN CBMG | Liu Tony | 1,104,933 5.700% | 74,293 (+7.21%) | Filing History |